Pulmozyme
My Prescription
Payment
Select pharmacy
$143.85
Print or send this coupon to your phone
AlbertsonsPowered byAbout Pulmozyme
Drug Details
Dornase alfa, marketed under the brand name Pulmozyme, is a medication designed to aid individuals with cystic fibrosis in improving their breathing and minimizing lung infection risks. It works by thinning and loosening the thick mucus in the lungs, making it easier to clear. This is achieved as dornase alfa, a form of the DNase I enzyme naturally produced by the body, breaks down the DNA in mucus that contributes to its stickiness. Administered via a nebulizer, which converts the solution into an inhalable mist, this treatment is typically used alongside other therapies like chest physical therapy and nutritional supplements. While it generally does not interact with other medications, common side effects may include throat pain, chest pain, and changes in voice. Always consult with healthcare professionals before starting any new treatment.
Price history for Pulmozyme
1 Plas Cont, 2.5ML of 2.5MG/2.5ML
Average retail price for Pulmozyme
Average SaveHealth price for Pulmozyme
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Pulmozyme dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 2.5ML of 2.5MG/2.5ML | 1 Plas Cont | $150.02 | $150.02 |
| 2.5ML of 2.5MG/2.5ML | 2 Plas Conts | $283.10 | $141.55 |
| 2.5ML of 2.5MG/2.5ML | 3 Plas Conts | $416.15 | $138.72 |
Pulmozyme FAQs
Pulmozyme is used to help improve lung function in individuals with cystic fibrosis by thinning and loosening mucus in the airways, making it easier to clear from the lungs.
Yes, Pulmozyme (dornase alfa) requires a specific type of nebulizer for administration. It is important to use a nebulizer system that is compatible with Pulmozyme to ensure proper delivery of the medication. Patients should follow the manufacturer's instructions or consult with their healthcare provider to determine the appropriate nebulizer system for Pulmozyme.
The main side effects of Pulmozyme (dornase alfa) can include voice changes, sore throat, rash, chest pain, and conjunctivitis. Some individuals may also experience shortness of breath, fever, or a runny nose. It is important for patients to report any severe or persistent side effects to their healthcare provider.